Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$18.24 +0.38 (+2.10%)
At close: Sep 29, 2026 · 4:00 PM EDT

Syndax Pharmaceuticals (SNDX) Receivables - Net (2024 - 2026)

Updated

Syndax Pharmaceuticals (SNDX) recorded Receivables - Net of $45.07 million in Q2 2026, up 131.7% from $19.45 million a year earlier and up 18.2% from the prior quarter.

Analysis

Syndax Pharmaceuticals (SNDX) Receivables - Net (2024 - 2026) Analysis & Trends

At the end of FY2025, Syndax Pharmaceuticals reported Receivables - Net of $38 million, up 399.8% from FY2024.

  • Across earlier years, Receivables - Net came in at $7.6 million in FY2024.
  • On a year-over-year basis, Receivables - Net has increased for three consecutive quarters.
  • Per Business Quant, the preceding three quarters came in at $38.12 million (Q1 2026), $38 million (Q4 2025) and $25.4 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Syndax Pharmaceuticals 1.59 Bn -137.74 Mn 69.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 45.07 Mn
Mar 31, 2026 38.12 Mn
Dec 31, 2025 38.00 Mn
Sep 30, 2025 25.40 Mn
Jun 30, 2025 19.45 Mn
Mar 31, 2025 15.72 Mn
Dec 31, 2024 7.60 Mn
API Access

Syndax Pharmaceuticals Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=SNDX&period=max&api_key=YOUR_API_KEY